Connective Tissue Diseases  >>  Tracleer (bosentan)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tracleer (bosentan) / J&J, Roche
RAPIDS-2, NCT00077584: Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma

Completed
3
188
US, Canada
Bosentan 62.5 mg, Ro 47-0203, Bosentan 125 mg, Placebo
Actelion
Digital Ulcers, Systemic Sclerosis
03/05
05/05
RAPIDS 2 OL, NCT00319696 / 2004-000632-82: Bosentan in Digital Ulcers

Completed
3
116
Canada, US, Europe
Bosentan 62.5 mg, Bosentan 125 mg
Actelion
Digital Ulcers
01/09
01/09
NCT00070590: Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma

Completed
2/3
132
US, Europe, RoW
Bosentan
Actelion
Pulmonary Fibrosis, Scleroderma, Systemic
09/05
09/05
BUILD 2 OL, NCT00319033 / 2004-000631-28: Open-label Study With Bosentan in Interstitial Lung Disease

Completed
2/3
132
US, Canada, Europe, RoW
bosentan
Actelion
Interstitial Lung Disease, Scleroderma
02/06
02/06

Download Options